The in vivo effects of CAMP-hMT1A were evaluated by stereotaxic injection of 3 μg of CAMP-hMT1A protein into the SN of MPTP-induced acute PD model mice, as shown in Fig. 7a. This evidence concerns the gene CAMP and Parkinson disease.